News |

Camgenium Launches Foundation Platform: Pre-certified Infrastructure For Connected Medical Device Development

  • Foundation Platform provides pre-certified firmware, cloud infrastructure and compliance reporting 
  • Enables connected medical device teams to focus on clinical innovation, not compliance infrastructure 
  • Reduces development complexity while supporting secure, scalable and regulatory-compliant deployment 

17th June 2026, Cambridge, UK / Camgenium has announced the launch of its Foundation Platform, a pre-certified infrastructure spanning firmware, cloud and compliance for connected medical device manufacturers. By providing security, connectivity, regulatory infrastructure and cloud hosting as a ready-built foundation, the platform allows OEM development teams to focus their engineering effort on clinical differentiation rather than building the compliance infrastructure from scratch. 

Building a connected medical device means solving two separate engineering challenges simultaneously. Addressing these requirements from scratch is slow and expensive, demanding specialist expertise across firmware security, cloud infrastructure, regulatory affairs and quality management that is rarely held in full by a single development team. The clinical proposition demands deep domain expertise. But before a single line of clinical code can be written, teams face years of infrastructure work: secure boot, hardware-backed encryption, key management, over-the-air firmware distribution, device-to-cloud connectivity, and audit-grade logging. These systems must also meet regulatory expectations from day one, with documentation embedded throughout the design process. 

Focus on clinical innovation, not compliance infrastructure 

Foundation addresses this through a complete, pre-certified platform spanning the full hardware and software stack. At the centre is Foundation Core; Camgenium’s Regulation on Chip (RoC), pre-certified firmware for the Nordic nRF5340 system-on-chip which delivers IEC 62304-compliant communications, audit-grade logging, secure boot, encrypted over-the-air firmware updates and independent safety monitoring as a standard SPI peripheral. The customer’s application processor communicates with Foundation Core over SPI, inheriting its compliance properties without the cost and complexity of building or documenting those services independently. All clinical code, algorithms and domain-specific innovation remain the customer’s intellectual property; Foundation is the infrastructure they use, not the IP they licence. 

Connected devices communicate with Foundation Cloud, Camgenium’s own medical-grade cloud infrastructure, developed to IEC 62304 Class B medical device software standards and operated to ISO 27001. Camgenium operates its own servers in the UK and US, with EU infrastructure in deployment, providing full data residency control alongside compliance with NHS DSPT, HIPAA, SOC 1, SOC 2, GDPR and Cyber Essentials. Cloud connectivity is included within the Foundation Core licence at no additional charge. Each device is assigned a dedicated cloud microservice at provisioning, enabling context-aware AI model delivery, FHIR integration and over-the-air firmware management across the full device fleet. 

Automate compliance across the product lifecycle 

Foundation Reporting completes the compliance picture by generating twelve categories of regulatory report, automatically and continuously covering device integrity, risk control status to ISO 14971:2019, software bill of materials (SPDX 2.3), AI model governance to ISO 42001:2023, fleet security and cloud infrastructure compliance. Evidence that would require sustained effort across regulatory affairs, cybersecurity, firmware engineering and machine learning specialisms is produced from live system telemetry, without manual data entry or retrospective documentation. The platform is continuously maintained against the requirements of IEC 62304:2006+AMD1:2015, ISO 13485:2016, ISO 27001:2022, IEC 60601-4-5:2021, IEC 81001-5-1, EU MDR 2017/745, FDA QMSR and UKCA. 

“Foundation Core packages the regulatory infrastructure that every connected medical device needs — secure boot, compliant communications, audit-grade logging — into a single Nordic chip, certified once and reused many times,” said Dr Philip Gaffney OBE, Chief Executive Officer of Camgenium. “The customer’s application talks to Foundation Core over SPI. From their perspective, they are acquiring a compliant communications component, not undertaking a regulatory programme.” 

Early versions of the Foundation Platform have been supplied to the Cambridge University Department of Engineering for six consecutive years, where final-year students use the platform on Nordic development kits for degree-counted medical device projects. The platform is available to connected medical device manufacturers under a long-term partnership model, with SaaS pricing structured per active device under management and inclusive of connectivity, all twelve report types, software maintenance, security patches and regulatory alignment updates. Camgenium partners with customers for the full product lifecycle, from prototype through certification, deployment, post-market surveillance and decommissioning. 

To learn more about Foundation Platform, visit: https://www.camgenium.com/foundation/ 

ENDS

For further information, please contact:

Sciad Communications, Media Relations
Jasmin Shearan / Maria Taylor
E: pressteam@sciad.com

T:+442034057892

Notes for Editors

About Camgenium 

Camgenium specialises in the rapid development and deployment of regulatory compliant medical AI models, software and connected hardware medical devices. Established in 2007, Camgenium has a reputation for regulatory excellence, working to standards including ISO 13485, ISO 27001, GxP and the NHS Data Security & Protection Toolkit. 

Camgenium has developed market-leading AI solutions derived from >100m global healthcare records as well as software products that have been deployed worldwide to tens of thousands of patients. Camgenium is certified by the NHS to access national data sets for development of AI and ML algorithms. 

The company has developed proprietary technology to accelerate development and has world-class in-jurisdiction medical hosting facilities servicing Europe and the USA. 

Cambridge-based, Camgenium has a client-centric approach, offering a complete service model from initial product concept through development, production, and deployment to decommissioning. The company can take regulatory responsibility for the whole product lifecycle and can deploy globally. 

Camgenium has assembled a best-in-class expert team of engineers, scientists and mathematicians.  

Camgenium is the trading name of L2S2 Ltd. 

To discover more about Camgenium, please visit www.camgenium.com

Camgenium

Camgenium

Camgenium specialises in the rapid development and deployment of regulatory compliant medical AI models, software and connected hardware medical devices. Established in 2007, Camgenium has a reputation for regulatory excellence, working to standards including ISO 13485, ISO 27001, GxP and the NHS Data Security & Protection Toolkit. Camgenium has developed market-leading AI solutions derived from >100m global healthcare records as well as software products that have been deployed worldwide to tens of thousands of patients. Camgenium is certified by the NHS to access national data sets for development of AI and ML algorithms. The company has developed proprietary technology to accelerate development and has world-class medical hosting facilities in the UK, also servicing Europe, USA and Canada. It also has operations in New Zealand.  Cambridge based Camgenium has a client-centric approach, offering a complete service model from initial product concept through development, production, and deployment to decommissioning. The company can take regulatory responsibility for the whole product lifecycle and can deploy globally. Camgenium has assembled a best-in-class expert team of engineers, scientists and mathematicians. The team’s commitment to engineering excellence is demonstrated by its pro bono work teaching medical device design to students at Cambridge University Engineering Department, educating the next generation of medical device engineers.  Camgenium is the trading name of L2S2 Ltd. To discover more about Camgenium, please visit www.camgenium.com

Visit website



Share


Got an innovation you need bringing to life?

We’d love to hear from you! Head to our contact page to start a conversation.

Photo of Emily Blythe